These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23670062)

  • 1. Impact of different skin conditions on quality of life.
    Sampogna F; Tabolli S; Abeni D
    G Ital Dermatol Venereol; 2013 Jun; 148(3):255-61. PubMed ID: 23670062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions.
    Sampogna F; Picardi A; Chren MM; Melchi CF; Pasquini P; Masini C; Abeni D
    Psychosom Med; 2004; 66(4):620-4. PubMed ID: 15272112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients.
    Sampogna F; Spagnoli A; Di Pietro C; Pagliarello C; Paradisi A; Tabolli S; Abeni D
    J Invest Dermatol; 2013 Jan; 133(1):104-9. PubMed ID: 22832497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
    Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
    Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Categorization of Skindex-29 scores using mixture analysis.
    Nijsten T; Sampogna F; Abeni D
    Dermatology; 2009; 218(2):151-4. PubMed ID: 19060458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.
    Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S
    J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe impairment of quality of life in Hailey-Hailey disease.
    Gisondi P; Sampogna F; Annessi G; Girolomoni G; Abeni D
    Acta Derm Venereol; 2005; 85(2):132-5. PubMed ID: 15823906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Psychosocial Burden of Skin Conditions and Symptoms: Measuring the Attributable Fraction.
    Sampogna F; Tabolli S; Giannantoni P; Paradisi A; Abeni D
    Acta Derm Venereol; 2016 Jan; 96(1):60-3. PubMed ID: 25766753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.
    Smidt AC; Lai JS; Cella D; Patel S; Mancini AJ; Chamlin SL
    Arch Dermatol; 2010 Aug; 146(8):865-9. PubMed ID: 20713817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosomatic assessment of skin diseases in clinical practice.
    Picardi A; Pasquini P; Abeni D; Fassone G; Mazzotti E; Fava GA
    Psychother Psychosom; 2005; 74(5):315-22. PubMed ID: 16088270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
    AlGhamdi KM; AlShammari SA
    Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
    Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
    Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.
    Augustin M; Wenninger K; Amon U; Schroth MJ; Küster W; Chren M; Kupfer J; Gieler U
    Dermatology; 2004; 209(1):14-20. PubMed ID: 15237262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turkish version of Skindex-29.
    Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
    Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited role of marital status in the impact of dermatological diseases on quality of life.
    Tabolli S; Pagliarello C; Di Pietro C; Abeni D
    Eur J Dermatol; 2012; 22(5):672-7. PubMed ID: 22947338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of vitiligo: patient characteristics associated with quality of life.
    Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
    J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life assessment in the routine clinical practice of a dermatology unit.
    Tabolli S; Baliva G; Lombardo GA; Sampogna F; Di Pietro C; Mannooranparampil TJ; Alvetreti G; Abeni D
    Eur J Dermatol; 2006; 16(4):409-15. PubMed ID: 16935800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and psychological adaptation of Korean adolescents with vitiligo.
    Choi S; Kim DY; Whang SH; Lee JH; Hann SK; Shin YJ
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):524-9. PubMed ID: 19807826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.